BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Hepatitis B clinical trials and catalysts

Active industry-sponsored trials on ClinicalTrials.gov for hepatitis B: 93 (51 sponsors; 27 newly posted in the last 180 days, 2 stopped in the last 180 days; 8 new-entrant sponsors). Momentum score 24.7, rank 13 of 91 on the disease-area ranking. As of 2026-11-18.

Phase distribution: Early Phase 1 2, Phase 1 25, Phase 2 38, Phase 3 16, Phase 4 2, N/A 10.

Most active sponsors, by phase

SponsorActive trialsBy phaseNew (window)Upcoming readouts
Fujian Akeylink Biotechnology Co., Ltd.5P3 2, P2 2, P1 122
Beijing Continent Pharmaceutical Co, Ltd.2P3 200
PT Bio Farma2P3 211
Ausper Biopharma Co., Ltd.12P3 1, P1 3, P2 7, NA 153
Grand Theravac Life Sciences (Nanjing) Co., Ltd.5P3 1, EARLY_P1 1, P2 2, P1 111
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3P2 2, P3 110
Fujian Shengdi Pharmaceutical Co., Ltd.2P2 1, P3 110
Gilead Sciences GILD2P3 1, P2 100
GC Biopharma Corp1P3 100
LG Chem1P3 100
Sanofi SNY new entrant1P3 110
Shanghai Zhimeng Biopharma, Inc.1P3 100
Tanabe Pharma Corporation new entrant1P3 110
GlaxoSmithKline6P4 1, P1 2, P2 322
Xiamen Amoytop Biotech Co., Ltd.5NA 1, P1 434
AusperBio Therapeutics Inc.3P1 1, P2 221
Suzhou HepaThera Biotech Co., Ltd.3P2 311
bioLytical Laboratories2NA 202
Epigenic Therapeutics, Inc2P1 1, EARLY_P1 101
Lion TCR Pte. Ltd.2P2 1, P1 101
Precision BioSciences, Inc. DTIL2NA 1, P1 101
Aligos Therapeutics ALGS1P2 101
Arbutus Biopharma Corporation ABUS1NA 100
Asia Cell Therapeutics (Shanghai) Co., Ltd.1P2 101
Beijing Tuohua Weiye Biotechnology Co., Ltd.1P2 101

New-entrant sponsors: Sanofi, Tanabe Pharma Corporation.

Recently stopped trials

Upcoming trial readouts (next 90 days)

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12-01 est.P3Fujian Akeylink Biotechnology Co., Ltd.NCT07090759 To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to AntiChronic Hepatitis brecruiting526
2026-12-12 est.P2Ausper Biopharma Co., Ltd.NCT07137910 A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)Chronic Hepatitis Brecruiting200
2026-12-18 est.P3Ausper Biopharma Co., Ltd.NCT07246889 Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)Chronic Hepatitis Bactive not recruiting577
2026-12-31 est.P1/P2Beijing Tuohua Weiye Biotechnology Co., Ltd.NCT07413549 Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B CirrhosisDecompensated Hepatitis B Cirrhosisrecruiting76
2027-02 est.P2Suzhou HepaThera Biotech Co., Ltd.NCT07245953 A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus InfectionChronic Hepatitis Bactive not recruiting60

Readouts in the last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-10-27P2Gilead Sciences GILDNCT02932150 Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus InfectionChronic Hepatitis Bactive not recruiting150
2026-10-01 est.P2Fujian Akeylink Biotechnology Co., Ltd.NCT07709520 Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis BChronic Hepatitis Brecruiting80
2026-09 est.P1/P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06452693 A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis BHepatitis B, Chronicunknown162
2026-08-30 est.P2Fujian Shengdi Pharmaceutical Co., Ltd.NCT06425341 A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Chronic Hepatitis Brecruiting369
2026-08-05P2Brii Biosciences LimitedNCT06491563 Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)For Treatment of Chronic Hepatitis B Virus Infectioncompleted150
2026-08-02 est.P2Ausper Biopharma Co., Ltd.NCT06829329 Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)Chronic Hepatitis Bactive not recruiting105
2026-07-28P3Beijing Continent Pharmaceutical Co, Ltd.NCT07343778 A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver CirrhosisChronic Hepatitis B With Hepatic Fibrosiscompleted337
2026-07-27P2Beijing Continent Pharmaceutical Co, Ltd.NCT07417553 A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver FibrosisChronic Hepatitis B-related Liver Fibrosiscompleted67
2026-06-30 est.P3GC Biopharma CorpNCT05686759 A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.Hepatitis Brecruiting105
2026-06-22P2Beijing Continent Pharmaceutical Co, Ltd.NCT07364448 A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver FibrosisChronic Hepatitis B With Hepatic Fibrosiscompleted411
2026-06-07 est.P2Shanghai Argo Biopharmaceutical Co., Ltd.NCT07135349 A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis BChronic Hepatitis Bactive not recruiting209

Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "hepatitis B"); readouts matched by condition text. Registry counts only; not a forecast.

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.